PRVA
HealthcarePrivia Health Group, Inc. · Medical - Healthcare Information Services · $3B
What is Privia Health Group, Inc.?
Privia Health Group is a national physician-enablement company headquartered in Arlington, Virginia. It partners with medical groups, health plans, and health systems to help independent doctors run better practices and deliver higher-quality care.
Privia Health makes money by providing technology, management services, and value-based care infrastructure to physician practices across the United States. Its platform reduces administrative burden on doctors, supports payer negotiations through a single-TIN medical group structure, and connects providers with accountable care organizations. Health plans and health systems pay for access to Privia's network and tools, aligning financial incentives around patient outcomes rather than visit volume.
Privia Health Group, Inc. was incorporated in 2021 and is headquartered in Arlington, Virginia.
- Population health and workflow technology for independent providers
- Management services organization reducing physician administrative work
- Single-TIN medical group for payer negotiation and clinical integration
- Accountable care organization driving value-based care coordination
- Payer and purchaser network connecting providers with new patient populations
Is PRVA a Good Stock to Buy?
UQS Score rates PRVA as Below Average overall.
Among the brighter spots in Privia Health's profile are its Growth and Risk pillars, both rated Good. The company is expanding its physician network and value-based care footprint, and its risk profile does not raise immediate red flags relative to sector peers.
The Quality and Moat pillars both register as Weak, suggesting the business has not yet built durable competitive advantages or demonstrated the financial efficiency typical of higher-rated healthcare platforms.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does PRVA pay dividends?
No — Privia Health Group, Inc. does not currently pay a dividend.
Privia Health does not currently pay a dividend. As a growth-oriented physician-enablement platform, the company directs available capital toward expanding its provider network, technology capabilities, and value-based care contracts rather than returning cash to shareholders through distributions.
When does PRVA report earnings?
Privia Health reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's recent results have reflected ongoing network expansion and growth in attributed lives under value-based arrangements. Revenue trajectory has been positive, though profitability metrics remain a focus area given the Weak Quality pillar rating.
For the most recent quarter's results and guidance, visit Privia Health Group's investor relations page directly.
PRVA Price History
-27.9% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Privia Health Group, Inc.?
Based on Privia Health Group, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
PRVA Long-term Outlook
Privia Health's Good Growth pillar suggests the business has meaningful expansion potential ahead, driven by continued physician recruitment and deeper penetration of value-based care contracts. The Good Risk pillar indicates the near-term fundamental outlook is not heavily burdened by financial or operational stress. However, the Weak Quality and Moat pillars temper longer-term confidence — the company will need to demonstrate improving unit economics and defensible competitive positioning to move the overall UQS rating higher.
Growth drivers
- Expansion of the physician network across new geographies and specialties
- Growth in value-based care attributed lives and shared savings arrangements
- Increasing adoption of Privia's technology and management services platform
Key risks
- Weak moat leaves the platform vulnerable to competition from larger health systems or rival enablement companies
- Neutral valuation means the stock offers limited margin of safety if growth disappoints
- Weak quality metrics suggest profitability and capital efficiency remain work-in-progress
PRVA vs Peers
Privia Health operates in a broader digital health and care-enablement landscape alongside several other growth-stage companies.
Heartflow focuses on AI-driven cardiac diagnostics rather than physician practice management, targeting a narrower clinical use case.
10x Genomics operates in genomics research tools, a fundamentally different segment from Privia's physician-enablement and value-based care model.
Hinge Health delivers digital musculoskeletal care programs, competing for employer and health plan budgets but through a direct-to-patient model distinct from Privia's provider-facing approach.
Frequently Asked Questions
What does Privia Health Group do?
Privia Health is a physician-enablement company that partners with independent medical groups, health plans, and health systems. It provides technology, management services, and value-based care infrastructure to help doctors reduce administrative work, improve patient outcomes, and participate in accountable care arrangements.
Does PRVA pay dividends?
No, Privia Health does not pay a dividend. The company reinvests available capital into growing its physician network and expanding its value-based care platform rather than distributing cash to shareholders.
When does PRVA report earnings?
Privia Health follows a standard quarterly earnings cadence for US-listed companies. The company does not pre-announce specific dates far in advance, so check Privia Health's investor relations page for the most current schedule.
Is PRVA a good stock to buy?
UQS Score rates PRVA as Below Average overall. While the Growth and Risk pillars show relative strength, the Weak Quality and Moat ratings indicate the company has not yet established durable competitive advantages or strong financial efficiency. The full pillar breakdown is available to Pro members.
Is PRVA overvalued?
The UQS Valuation pillar for PRVA is rated Neutral, suggesting the stock is neither clearly cheap nor obviously expensive relative to its fundamentals. Investors seeking a deeper look at valuation metrics can access the complete analysis through a UQS Pro account.
How does PRVA compare to its competitors?
Privia Health's closest listed peers in the digital health space include Heartflow, 10x Genomics, and Hinge Health. Each operates in a distinct niche — Privia's differentiation lies in its physician-practice management and value-based care network model rather than diagnostics or direct-to-patient care.
What is PRVA's market cap bracket?
Privia Health is classified as a mid-cap stock. This places it in a tier where growth potential remains meaningful but the company has not yet reached the scale of large-cap healthcare incumbents.
Who founded Privia Health Group?
Privia Health's founding and leadership history is publicly available through the company's official investor relations materials and SEC filings. The corporate entity was established in 2021, though the underlying business has operated since 2007.
Is PRVA a long-term quality investment?
As a long-term quality indicator, PRVA's Below Average UQS Score reflects current weaknesses in Quality and Moat that investors should weigh carefully. The Good Growth pillar offers some optimism, but sustained improvement in competitive positioning and financial efficiency would be needed to support a stronger long-term quality case.
What is the main competitive advantage of Privia Health?
Privia Health's primary differentiator is its integrated platform combining technology, management services, and value-based care contracting under one roof for independent physicians. However, the UQS Moat pillar rates this advantage as Weak, indicating the company has not yet built a clearly defensible position relative to sector peers.
What sector does PRVA belong to?
Privia Health operates in the Healthcare sector, specifically within the physician-enablement and value-based care sub-segment. It sits at the intersection of healthcare services and health technology, serving providers, health plans, and health systems.
Unlock Full PRVA Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings
- ✓Access detailed financial metrics and efficiency indicators
- ✓Compare PRVA against sector peers on every pillar
- ✓Track changes to Quality, Moat, and Valuation over time
- ✓Get the complete analyst-grade breakdown in one place
Pro Analysis
PRVA — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | 47.4 | 17.8 | 28.0 | 79.9 | 69.3 | 64.1 | +0.5 |
| May 7, 2026 | 46.9 | 24.2 | 28.0 | 78.9 | 69.2 | 51.2 | +0.1 |
| May 3, 2026 | 46.8 | 24.2 | 28.0 | 78.9 | 69.2 | 50.7 | -0.1 |
| May 2, 2026 | 46.9 | 24.2 | 28.0 | 78.9 | 69.2 | 51.3 | +0.1 |
| Apr 19, 2026 | 46.8 | 24.2 | 28.0 | 78.5 | 69.2 | 51.3 | -0.1 |
| Apr 18, 2026 | 46.9 | 24.2 | 28.0 | 78.5 | 69.2 | 52.0 | -2.0 |
| Apr 14, 2026 | 48.9 | 24.2 | 28.0 | 78.5 | 69.2 | 65.0 | 0.0 |
| Apr 12, 2026 | 48.9 | 24.2 | 28.0 | 78.5 | 69.2 | 65.5 | -0.2 |
| Apr 11, 2026 | 49.1 | 24.2 | 28.0 | 78.5 | 69.2 | 66.5 | 0.0 |
| Apr 9, 2026 | 49.1 | 24.2 | 28.0 | 78.7 | 69.2 | 66.5 | -0.2 |
PRVA — Pillar Breakdown
Quality
— 17.9/100 (25%)Privia Health Group, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 80.1/100 (20%)Privia Health Group, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 69.3/100 (15%)Privia Health Group, Inc. maintains a reasonable risk profile with manageable debt levels.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 64.3/100 (15%)Privia Health Group, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Moat
— 28/100 (25%)Privia Health Group, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for PRVA.
Score Composition
Financial Data
More Stock Analysis
How is the PRVA UQS Score Calculated?
The UQS (Unified Quality Score) for Privia Health Group, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Privia Health Group, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Privia Health Group, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.